The Promises and Perils of Real Options Valuation Technique.: An in-depth analysis of Real Options Valuation technique, in Pharmaceutical R&D industry. By means of a case study research method - Couverture souple

GUPTA, MAYANK

 
9783844310030: The Promises and Perils of Real Options Valuation Technique.: An in-depth analysis of Real Options Valuation technique, in Pharmaceutical R&D industry. By means of a case study research method
Couverture souple
ISBN 10 : 3844310037 ISBN 13 : 9783844310030
Editeur : LAP LAMBERT Academic Publishing, 2011

Synopsis

This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry.

Biographie de l'auteur

I have completed my MSc. program in Strategic Project Management (European). My research interests are in the areas of financial economics specifically on Efficient Market Hypothesis, and capital budgeting for making investment decisions under uncertain business environment, by capturing the value of new information, and managerial flexibility.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2011
Langue
anglais
ISBN 10 
3844310037
ISBN 13 
9783844310030
Reliure
Broché
Nombre de pages
76
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne